phosphorus binder

phosphorus binder

Therapeutics Any oral calcium–acetate or aluminum salt-based agent used in Pts with renal failure to bind both dietary and endogenous phosphorus; PBs ↑ GI excretion of phosphorus in Pts with chronic renal failure
References in periodicals archive ?
We also found that the co-occurrence network of genera was more complex in patients with ESRD before use of phosphorus-binder compared with normal controls, but the complexity declined after phosphorus binder therapy.
More studies with more samples and different phosphorus binders are needed.
Your doctor may also ask you to take a medicine called phosphorus binder. This medicine keeps you from absorbing phosphorus from your food.
For patients with high calcium, low phosphorus, and low iPTH, if they stop taking calcium, phosphorus binder, and Vitamin D active drugs, the process is considered as treatment; if they still take calcium, phosphate binder, and Vitamin D active drugs, the process is considered an improper treatment.
* Calcium carbonate/OSCAL[TM]/Tums[TM]/Phoslo[TM]/Renagel[TM]: Phosphorus binder must be taken with all meals to help decrease rate of bone loss.
Extended release niacin may be of some assistance, but for most patients with advanced renal disease, prescription phosphorus binders are usually a necessity.
He realizes the necessity of always carrying his phosphorus binders with him.
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Management of hyperphosphataemia can be achieved in three ways: a) removal of phosphorus during dialysis; b) dietary intervention; c) and/or use of phosphorus binders. However, dietary restriction and dialysis alone are usually ineffective for the control of phosphate balance in patients with advanced renal disease.
An open-label study of Niacinamide in Japanese hemodialysis patients who were not taking phosphorus binders found that dosages up to 1750 mg/d decreased serum phosphorus from 6.9 to 5.4 mg/dl, in addition, HDL cholesterol increased and LDL cholesterol declined during the 12 wk of treatment [22].
The authors speculated that the higher percentage of diarrhea was a result of co administration of phosphorus binders with high dose of nicotinamide [21].
Even with dietary restrictions and the use of phosphorus binders, many individuals with kidney failure will not achieve a phosphorus level of 5.5 mg/dL or less.